his left tibiotarsal joint, both hips, right elbow, and left shoulder, together with inflammatory pain in the cervical region. X-rays showed bilateral sacroiliitis, which had not been present at the time of the accident; the sedimentation rate was 50 mm in the first hour. The patient was HLA-B27 positive. On treatment with non-steroidal anti-inflammatory drugs there was a very gradual resolution of pain, with complete recovery only after one and a half years.
Case No 3
Patient No 3 born on 1 May 1951 suffered a slight injury to his right wrist on 16 August 1975, causing mechanical pain which was not improved by immobilisation in a cast. After 15 days the pain became inflammatory and then bilateral; after 21 days there was conjunctivitis and arthritis of both knees and the cervical spine. X-rays were normal. The sedimentation rate was 70 mm in the first hour. The patient was HLA-B27 positive. The past history included two episodes of urethritis in 1974, resolving after three days of antibiotics. On non-steroidal anti-inflammatory drugs the pain in the knee settled within one month and in the wrist within two months. The patient subsequently had two recurrences of arthritis: in 1977 inflammatory pain involved his spine, without radiological abnormalities, and in 1982 both iliac crests, both wrists, and the lumbar spine were affected, with radiological evidence for sacroiliitis. These two episodes each lasted seven days.
Discussion
These three cases appear to be examples of Reiter's syndrome provoked by trauma.' 9"1 We hope that others will report similar experiences and thus allow an assessment of the role of trauma in the genesis or initiation of Reiter's syndrome and a comparison with the situation in rheumatoid arthritis5 12 and ankylosing spondylitis.6
The medicolegal implications have been studied by European authors.4 6 7Like Jacoby, these authors separate two entities: (a) Usually (18% for Forestier, 4% for Jacoby) disease was already present, as shown by radiographs taken immediately after trauma, but was clinically non-apparent, and trauma triggered the symptoms which led to diagnosis. (b) Less often (3-5% for both Forestier and Jacoby) ankylosing spondylitis develops ab initio as a result of trauma.
During 10 years we observed five patients whose ankylosing spondylitis appeared to be generated (three cases) or unmasked (two cases) by trauma. Contrary to Jacoby's work the causative trauma was twice minimal. It affected peripheral joints in three cases. Inflammatory episodes involved preferentially the traumatised joints throughout the whole course of the disease.
Wisnieskil proposed a hypothesis of an antigen-antibody reaction after trauma in genetically predisposed patients. 860
New antigens might be exposed through the trauma, leading to the development of autoimmune phenomena. This hypothesis is supported by other studies,' ' which tend to indicate that ankylosing spondylitis is a reactive arthritis following infection with various gram-negative organisms. Cross reactivity between infecting organisms and self components could be involved. The reason why some individuals develop Reiter's syndrome and others ankylosing spondylitis remains a mystery. It will be informative to seek differences in the genetic map of HLA-B27 positive patients which give rise to either disease. H6pital Jean Bernard, 86021 Poitiers, Cedex, France.
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Mepacrine induced hepatitis SIR, When mepacrine was introduced in 1930 as an antimalarial it was frequently noted to cause yellow discoloration of the skin.' Rarely it caused jaundice and fatal hepatitis, introducing the possibility of serious confusion with the common skin discoloration.2 Hepatitis Correspondence 861 due to mepacrine therapy has not been reported during therapy of connective tissue disorders. In view of this we describe such a case.
A 37-year-old woman presented with an 18-month history of malaise, mouth ulcers, and arthralgias. From the age of 18 she had a persistent telangiectatic facial rash, similar to that of systemic lupus erythematosus, and from the age of 25 she had recurrent migraine and frequent episodes of bronchitis with asthma. Skin tests to common allergens were negative, but there was a strong family history of atopic disease. Full blood count and complement levels were normal, the erythrocyte sedimentation rate was 4 mm/lst h, and rheumatoid factor and antinuclear antibody tests were negative. Parotid secretion studies and labial salivary gland biopsy were normal, and skin biopsy did not show immunoglobulin deposition. She was considered to have an undifferentiated connective tissue disorder and received trials of hydroxychloroquine and chloroquine without benefit. After she complained of nausea and blurred vision the chloroquine was stopped. Liver function tests were normal, and mepacrine was substituted at a dose of 100 mg daily, increasing after two weeks to 300 mg daily. The patient was warned of the possibility of skin yellowing. Six weeks later she reported that her skin and eyes had abruptly turned yellow accompanied by feelings of lethargy, loss of appetite, itching and tender cervical lymphadenopathy. She was instructed to stop the mepacrine, but four weeks later her urine contained urobilinogen, her y-glutamyltransferase was 264 IU/l (normal (n)<65 IU/l), alanine transaminase 210 IU/I (n<45 IU/l), aspartase transaminase 107 IU/I (n<41 IU/l), and alkaline phosphatase 160 IU/l (n<105 IU/l). However, the bilirubin (5 [tmolUl) was normal, indicating that she was not jaundiced. An absolute eosinophil count of 680/mm3 (0-68x l09/l) was noted. Serological tests for hepatitis A and B and cytomegalovirus were negative. Further investigations were considered unnecessary as the liver function tests gradually improved and after two months were normal. The skin and sclerae remained yellow for two months after mepacrine was stopped.
In this patient the systemic symptoms, scleral yellowing, and urinary urobilinogen suggested hepatitis. The liver function tests supported this diagnosis, but the normal bilirubin indicated that the yellow discoloration was due to mepacrine. Mepacrine hepatitis associated with therapeutic doses is an idiosyncratic, unpredictable reaction similar to that caused by halothane. In addition to eosinophilia and lymphadenopathy, fever, rashes, and arthralgias may occur, features commonly found in the connective tissue diseases. Liver histology is similar to viral hepatitis2 or acute massive necrosis may result) The precise pharmacokinetics of mepacrine are not known but, like its fellow 4-aminoquinoline, chloroquine, it has an unusually large volume of distribution being widely distributed and bound in liver, lungs, spleen, adrenal, skin, and leucocytes. 
